Ingen Launches Their New Medical Division Commercial
September 12 2013 - 10:00AM
Ingen Technologies Inc. (OTC:IGNT), (http://ingen-tech.com)
announces today that it has launched a global consumer commercial
for its medical division at the same time when 100 Oxyview Units
were shipped to the Department of Homeland Security on September 5,
2013; where recently the Department of Homeland Security purchased
100 Oxyview Units for the US Coast Guard and continues to have a
serious interest in the patented respiratory products manufactured
by Ingen Technologies.
The commercial can be seen on the OTC Video tab at:
http://www.otcmarkets.com/stock/IGNT/video-and-presentations
The company has received large purchase orders from the
Department of the Interior and the Department of Homeland Security
in the past 90 days; an indication that the proprietary patented
medical technology is of serious consideration for use with various
government and commercial applications.
"The commercial was launched as part of our new marketing
program to target the projected $50M annual sales for Ingen. There
is serious interest in the acquisition of our medical division, and
we are undecided on accepting an offer at this time. Our new
Telecom Division has recently landed contracts with TATA
Communications and China Unicom, two giants in the global telecom
services industry. Our focus is on revenues, and our medical
division has suddenly demonstrated great potential with the $8B
Respiratory markets," stated Gary Tilden, Chairman.
Safe Harbor for Forward-Looking Statements: This news release
includes forward-looking statements. While these statements are
made to convey to the public the company's progress, business
opportunities and growth prospects, readers are cautioned that such
forward-looking statements represent management's opinion. Whereas
management believes such representations to be true and accurate
based on information and data available to the company at this
time, actual results may differ materially from those described.
The company's operations and business prospects are always subject
to risk and uncertainties. Important factors that may cause actual
results to differ are and will be set forth in the company's
periodic filings with the U.S. Securities and Exchange
Commission.
CONTACT: Gary Tilden
951-688-7840
www.ingen-tech.com
info@ingen-tech.com
www.useatmc.com
Ingen Technologies (CE) (USOTC:IGNT)
Historical Stock Chart
From Apr 2024 to May 2024
Ingen Technologies (CE) (USOTC:IGNT)
Historical Stock Chart
From May 2023 to May 2024